Beam Therapeutics Inc (BEAM)

CapEx to Revenue

492.65%

Quarterly · Period ending:

BEAM logo

BEAM CapEx to Revenue

Latest reported492.65%
BEAM Quarterly CapEx/Revenue (0.00% → 492.65%)
High-resolution chart · PNG

BEAM capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Beam Therapeutics Inc CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
492.6531%
7.0326%
3.2723%
51.6704%
37.0423%
41.0308%
9.8779%
11.0519%
16.6582%
32.9015%
1.1351%
46.2281%
80.4235%
24.8554%
41.2287%
74.606%
129.9784%
86.0887%
26.1783%
757.536%
269,733.3333%
191,300%
135,416.6667%
46,983.3333%
39,450%
50,766.6667%
36,000%
23,650%
109,750%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.